Clinical Potential of Biological Response Modifiers Combined with Chemotherapy for Gastric Cancer

2002 ◽  
Vol 19 (4) ◽  
pp. 255-260 ◽  
Author(s):  
Masahiko Shibata ◽  
Takeshi Nezu ◽  
Shigeru Fujisaki ◽  
Katsuyuki Andou ◽  
Ryouichi Tomita ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Biological Response ◽  
Biological Response Modifiers ◽  
Clinical Potential

scholarly journals Immunological studies on local administration of biological response modifiers for gastric cancer.

1987 ◽  
Vol 20 (7) ◽  
pp. 1682-1689
Author(s):  
Takao SUZUKI ◽  
Takenori OCHIAI ◽  
Takehide ASANO ◽  
Minoru MUKAI ◽  
Masahiro MARUYAMA ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Biological Response ◽  
Biological Response Modifiers ◽  
Local Administration

A Case of Malignant Melanoma Treated with a Combination of Anti-Cancer Drugs and Biological Response Modifiers.

1993 ◽  
Vol 55 (1) ◽  
pp. 43-46
Author(s):  
Jun YOSHIDA ◽  
Juichiro NAKAYAMA ◽  
Nobuyuki SHIMIZU ◽  
Shonosuke NAGAE ◽  
Yoshiaki HORI
Keyword(s):  
Malignant Melanoma ◽  
Biological Response ◽  
Biological Response Modifiers ◽  
Cancer Drugs ◽  
Anti Cancer

scholarly journals Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies

2018 ◽  
Vol 5 (11) ◽  
Author(s):  
Amal A Gharamti ◽  
Amy Rao ◽  
Paula E Pecen ◽  
Andrés F Henao-Martínez ◽  
Carlos Franco-Paredes ◽  
...  
Keyword(s):  
Severe Disease ◽  
Biological Response ◽  
Laboratory Diagnosis ◽  
Clinical Findings ◽  
Organ Involvement ◽  
Biological Response Modifiers ◽  
Biological Therapies ◽  
Acute Toxoplasmosis

Abstract We report the case of a 65-year-old patient with pseudolymphoma who developed acute toxoplasmosis following 6 cycles of rituximab and bendamustine therapy. Acute toxoplasmosis in the setting of biological response modifiers, rather than reactivation, is a unique unreported infection. The patient developed severe disease with multi-organ involvement, including retinitis, myocarditis, and myositis. We discuss the clinical findings, epidemiology, and laboratory diagnosis.

Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapy

Biotherapy ◽  
1992 ◽  
Vol 5 (2) ◽  
pp. 119-129 ◽  
Author(s):  
Gilda G. Hillman ◽  
Gabriel P. Haas ◽  
Werner H. Wahl ◽  
Denis M. Callewaert
Keyword(s):  
Cell Therapy ◽  
Adoptive Immunotherapy ◽  
Biological Response ◽  
Biological Response Modifiers ◽  
Cytotoxic Cell ◽  
Immunotherapy Of Cancer
Sign in / Sign up

Export Citation Format

Share Document